Information on the cost of generic drugs supplied by Teva is not collected centrally but supplies from Israeli company Teva represent a significant and important part of National Health Service medicines provision. We estimate that the total reimbursement cost of these medicines dispensed in the community may be in the region of £0.5 billion. This does not take account of the margin that pharmacies earn on the medicines they dispense. This margin is subsequently taken into account as contributing towards the target level of funding for community pharmacy as part of the community pharmacy contractual framework.
Israel plays an important role in helping supply medicines for the NHS. Some 100 million prescription items for medicines used in the community in England are estimated to come from companies based in Israel. Teva also funds clinical development in the United Kingdom, including research into dementia.